China's commercial health insurance market is undergoing a pivotal transformation. Premiums surged from CNY158.7bn ($21.9bn) in 2014 to CNY977.3bn in 2024, representing a CAGR of 20%, according to a new report jointly released by Swiss Re Institute and China Pacific Insurance. But as the country confronts ageing demographics, medical system reform, and changing healthcare demands, the focus is now shifting from scale to quality.